Unlocking the potential in rare disease research with decentralised trialsA survey by rare disease patient network Raremark found that 86% of the community members asked were interested Share XUnlocking the potential in rare disease research with decentralised trialshttps://pharmaphorum.com/views-analysis-patients/unlocking-the-potential-in-rare-disease-research-with-decentralised-trials/
2021 – The healthcare changes here to stay2020 was the year that changed everything, and as the new year begins many are wondering what awaits Share X2021 – The healthcare changes here to stayhttps://pharmaphorum.com/views-analysis-digital/2021-healthcare-change/
2021 Outlook: The future for life sciences customer experienceResearch from a large-scale survey of 1000+ senior pharma professionals has highlighted the divide between digitally adept companies Share X2021 Outlook: The future for life sciences customer experiencehttps://pharmaphorum.com/views-analysis-sales-marketing/2021-outlook-the-future-for-life-sciences-customer-experience/
Nine for 2021: The COVID-19 legacyIn the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that Share XNine for 2021: The COVID-19 legacyhttps://pharmaphorum.com/views-and-analysis/nine-for-2021-the-covid-19-legacy/
How Big Data will accelerate the future of digital medicine in 2021The pandemic has shed light on inefficiencies in healthcare systems, and provided an opportunity to adjust how we Share XHow Big Data will accelerate the future of digital medicine in 2021https://pharmaphorum.com/views-analysis-digital/the-future-of-digital-medicine-in-2021/
Moderna and BioNTech – who are they?Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA Share XModerna and BioNTech – who are they?https://pharmaphorum.com/views-and-analysis/moderna-and-biontech-who-are-they/
Pandemic has little impact on pharma’s reputation, says reportThe pandemic has had very little positive impact on the public’s perceptions of pharma although the industry has Share XPandemic has little impact on pharma’s reputation, says reporthttps://pharmaphorum.com/news/pandemic-has-little-impact-on-pharmas-reputation-says-report/
UK patients urged to self-care ahead of vaccine roll-outGPs in the UK have been urged to encourage patients to self-care, in advance of the anticipated roll-out Share XUK patients urged to self-care ahead of vaccine roll-outhttps://pharmaphorum.com/news/uk-patients-urged-to-self-care-ahead-of-vaccine-roll-out/
Healthcare’s COVID-19 backlog: how pharma can helpIQVIA’s Sarah Rickwood explores how pharma can help healthcare systems address treatment backlogs caused by the COVID-19 pandemic. Share XHealthcare’s COVID-19 backlog: how pharma can helphttps://pharmaphorum.com/views-analysis-patients/healthcares-covid-19-backlog-how-pharma-can-help/
